Immunogenicity of GSK Biologicals' Pandemic Influenza Vaccine (GSK1562902A) at Different Boosting Vaccination Schedules
Latest Information Update: 03 Jul 2023
At a glance
- Drugs Influenza A virus vaccine-H5N1 (Primary)
- Indications Influenza A virus H5N1 subtype
- Focus Pharmacodynamics; Registrational
- Sponsors GlaxoSmithKline; GSK
- 21 Oct 2016 New trial record